key: cord-0025067-3tlg571u
authors: Khakoo, Yasmin
title: Editor-In-Chief
date: 2021-12-31
journal: Pediatr Neurol
DOI: 10.1016/j.pediatrneurol.2021.12.002
sha: fd23445117d66cf6917fe5d1d88426eb16b65fe7
doc_id: 25067
cord_uid: 3tlg571u

nan

Editor-In-Chief Yasmin Khakoo, MD, FAAN Pediatric Neurology was founded by Ken Swaiman in 1985; Steve Roach served as the Editor from 2012 to 2021, bringing the journal to its current esteemed status. As the first female and South Asian Editor, I will continue to publish high-quality articles while adding my own imprint. Trained in child neurology at the University of California at San Francisco and neuro-oncology at Memorial Sloan Kettering Cancer Center in the 1990s, I never envisioned that 2022 would bring treatments for conditions such as spinal muscular atrophy and refractory pediatric brain tumors. Gene therapy, chimeric antigen receptor (CAR) T-cell therapy, and CRISPR gene editing technology offer hope to our patients, their families, and us. At the time of this writing, we are at the 2-year anniversary of the SARS-CoV-2 pandemic. Vaccines and antiviral agents suggest that safer times are imminent. This crisis has further exposed the deeprooted pandemic of health care access inequity and the associated dearth of under-represented individuals in health care leadership roles. And while physicians and nurses are leaving medicine at alarming rates, 1,2 applications to medical and nursing schools are paradoxically rising. 3,4 Many child neurology jobs remain unfilled. Succession planning requires encouraging enthusiastic trainees to enter child neurology, even those who may not at first glance seem to fit.

In the coming year, I will work with my team of Associate Editors (Nancy Bass, Sid Gospe, and Mustafa Shahin), our international editorial board, reviewers, authors, readers, and Elsevier staff members to optimize the manuscript submission/review workflow and update our website. We will curate child neurologyefocused original research, review articles, and opinion pieces on topics including but not limited to 1) diverse clinician and physician-scientist recruitment and retention, 2) the cost of health care delivery and the financial toxicity of illness, 3) the use of artificial intelligence to enhance our clinical capabilities, 4) the ethics of using early phase therapies for life-threatening illnesses, and 5) advocacy for the disabled. We will leverage social media to increase our visibility and complement traditional learning styles. We will continue to increase the diversity (racial, ethnic, and gender backgrounds, institutions, and career stages 5 ) of board members and reviewers while fostering trainee engagement and career development. Finally, we will address the work-life challenges child neurology professionals face from training through retirement.

Thank you to Steve Roach and Roger Brumback who epitomize #He4She and my parents, immigrant physicians who were my first role models. I look forward to working with you all.

E-mail address: Khakooy@mskcc.org